Why Novo Nordisk slashed prices of its weight-loss drug in India: 5 key points
诺和诺德诺和诺德(US:NVO) Invezz·2025-11-11 22:52

核心观点 - 诺和诺德将其重磅减肥药Wegovy在印度市场的价格下调高达33% [1] 市场策略 - 降价举措旨在扩大药物可及性并捍卫市场份额 [1]

Why Novo Nordisk slashed prices of its weight-loss drug in India: 5 key points - Reportify